One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   South America Pancreatic Cancer Therapeutics and Diagnostics Market

[ 英語タイトル ] South America Pancreatic Cancer Therapeutics and Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

Product Code : MDHC0088718
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 80
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD3750 / Question Form
5 User USD4250 / Question Form
Enterprise User USD7000 / Question Form
 - Bristol-Myers Squibb
- Canon Medical Systems
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GE Healthcare
- Hitachi Medical
- Novartis AG
- Pfizer Inc
- Philips Healthcare
- Siemens AG

[Report Description]

The market studied is majorly driven by factors, such as the increasing prevalence of pancreatic cancer and the increasing demand for diagnostic tests and treatments of this disease. As a result, many governments and non-profit organizations have taken initiatives to spread awareness regarding pancreatic cancer in the South American region.

Moreover, the technological advancements in diagnostics and treatments have have led to solutions that are more efficient. Hence, all these are the major factors that have propelled the growth of the market.

Key Market Trends

Chemotherapy Segment is Expected to Cover a Large Share of the Pancreatic Cancer Therapeutics & Diagnostics Market

Chemotherapy is the use of drugs to destroy cancer cells, usually by ending the cancer cells ability to grow and divide. A chemotherapy regimen, or schedule, usually consists of a specific number of cycles given over a set period of time. There is usually a rest period in between cycles. A patient may receive 1 drug at a time or a combination of different drugs given at the same time. Chemotherapy thus is an important part of multimodality pancreatic cancer treatment. After curative resection, adjuvant chemotherapy can significantly improve disease-free survival and overall survival. Therefore this will increase the demand for chemotherapy therapy in future, which is expected to help the market growth.

Competitive Landscape

South America is a developing region. Although the healthcare system in many countries in the region are not highly developed, these countries are spending more each year in their healthcare system. This has encouraged many global companies to enter the market and as a result, many global players in the pancreatic cancer therapeutics and diagnostics market are present in the region. These factors have made the region very competitive.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence and Prevalence of Pancreatic Cancer
4.2.2 Technological Advancements and Innovation of New Products
4.3 Market Restraints
4.3.1 High Costs Associated with Treatment and Diagnosis
4.3.2 Drug Toxicity and Side Effects
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Type
5.1.1 By Treatment Surgery Chemotherapy Targeted Therapy Other Treatments
5.1.2 By Diagnostics Imaging Biopsy Endoscopy Other Diagnostics
5.2 Geography
5.2.1 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Bristol-Myers Squibb
6.1.2 Canon Medical Systems
6.1.3 Eli Lilly and Company
6.1.4 F. Hoffmann-La Roche AG
6.1.5 GE Healthcare
6.1.6 Hitachi Medical
6.1.7 Novartis AG
6.1.8 Pfizer Inc
6.1.9 Philips Healthcare
6.1.10 Siemens AG




Recommended reports